ask="3.0000"
ask_size="1900"
average_daily_volume="56744"
bid="1.2900"
bid_size="1000"
book_value="0.9470"
change="-0.1001"
change_from_200_day_moving_average="-0.1131"
change_from_50_day_moving_average="0.0093"
change_from_52_week_high="-0.7101"
change_From_52_week_low="0.1499"
change_in_percent="-7.2014%"
close="1.2899"
dividend_pay_date="11/8/2012"
dividend_per_share="0.0000"
dividend_yield="0.0000"
earnings_per_share="-0.7500"
ebitda="-28.78M"
eps_estimate_current_year="-0.9200"
eps_estimate_next_quarter="-0.2000"
eps_estimate_next_year="-1.0700"
ex_dividend_date="11/9/2012"
float_shares="30545000"
high="1.3801"
high_52_weeks="2.0000"
last_trade_date="1/19/2017"
last_trade_price="1.2899"
last_trade_size="3000"
last_trade_time="3:57pm"
low="1.2611"
low_52_weeks="1.1400"
market_capitalization="49.84M"
moving_average_200_day="1.4030"
moving_average_50_day="1.2806"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.1700"
open="1.3800"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-8.0606%"
percent_change_from_50_day_moving_average="+0.7254%"
percent_change_from_52_week_high="-35.5050%"
percent_change_from_52_week_low="+13.1491%"
previous_close="1.3900"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.4678"
price_per_sales="6.9753"
revenue="7.70M"
shares_outstanding="38640000"
short_ratio="1.9000"
stock_exchange="NMS"
symbol="AVIR"
volume="77853"
weeks_range_52="1.1400 - 2.0000"
